41 filings
8-K
AVBP
ArriVent BioPharma, Inc. Common Stock
9 Sep 24
Regulation FD Disclosure
12:15pm
8-K
AVBP
ArriVent BioPharma, Inc. Common Stock
14 Aug 24
ArriVent BioPharma Reports Second Quarter 2024 Financial Results
4:05pm
8-K/A
AVBP
ArriVent BioPharma, Inc. Common Stock
9 Jul 24
Departure of Directors or Certain Officers
5:05pm
8-K/A
AVBP
ArriVent BioPharma, Inc. Common Stock
9 Jul 24
ArriVent Appoints Kristine Peterson to its Board of Directors
5:03pm
8-K
tixvjo c1
5 Jun 24
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
7:15am
8-K
ykbzmlnlkq76poyxd
16 May 24
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
4:11pm
10-Q
wxxyk 7pd8oe
8 May 24
Quarterly report
8:01am
8-K
8yjgjg6ah 5myu
8 May 24
ArriVent BioPharma Reports First Quarter 2024 Financial Results
8:00am
8-K
c7h39rf8thu0pa40
22 Apr 24
ArriVent Appoints Kristine Peterson to its Board of Directors
4:10pm
10-K
hlq2jjd9bmz 2zqyw
28 Mar 24
Annual report
5:14pm
8-K
8k0ftw
28 Mar 24
ArriVent Biopharma Reports Full Year 2023 Financial Results
4:15pm
S-8
56tlxy5bz
2 Feb 24
Registration of securities for employees
4:08pm
8-K
o61f2rmzt4uq1
30 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
424B4
v6gtru8
26 Jan 24
Prospectus supplement with pricing info
4:12pm
EFFECT
umi5 gn28i1c12
26 Jan 24
Notice of effectiveness
12:15am
SEC STAFF
1zsfu 9zrpk23ku0h8k
26 Jan 24
SEC staff action: Order
12:00am
S-1MEF
slkdsxykml7oo478n
25 Jan 24
Registration of additional securities for an S-1
7:37pm
CERT
h9ue65ddg
25 Jan 24
Certification of approval for exchange listing
12:32pm